144 related articles for article (PubMed ID: 9745495)
1. A second intrathymic injection of donor splenocytes improves survival of small bowel allografts.
Sun S; Greenstein SM; Kim DY; Schreiber TC; Schechner RS; Tellis VA
Transplant Proc; 1998 Sep; 30(6):2575-6. PubMed ID: 9745495
[No Abstract] [Full Text] [Related]
2. Prolonged small bowel allograft survival following repeated intrathymic injections of donor splenocytes and peripheral anti-lymphocyte treatment.
Sun S; Greenstein SM; Schechner RS; Tellis VA
Transplant Proc; 1999; 31(1-2):588-9. PubMed ID: 10083249
[No Abstract] [Full Text] [Related]
3. Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
Transplant Proc; 1994 Jun; 26(3):1582. PubMed ID: 8030046
[No Abstract] [Full Text] [Related]
4. Intrathymic injection of allogeneic cells induces indefinite survival of cardiac but not small bowel grafts.
Xia W; Sayegh MH; Kirkman RL
Transplant Proc; 1994 Jun; 26(3):1581. PubMed ID: 8030045
[No Abstract] [Full Text] [Related]
5. Immunomodulation with intrathymic injection of donor splenocytes followed by CTLA4Ig therapy prolongs small intestinal allograft survival.
Greenstein SM; Sun S; Schechner RS; Tellis VA
Transplant Proc; 1997; 29(1-2):1065-6. PubMed ID: 9123201
[No Abstract] [Full Text] [Related]
6. Tolerance to experimental cardiac allografts but not xenografts is induced after simultaneous neonatal intrathymic inoculation with allo and xenogeneic cells.
Shen Z; Mohiuddin M; Goldstein C; Yokoyama H; DiSesa VJ
Transplant Proc; 1996 Apr; 28(2):719-20. PubMed ID: 8623363
[No Abstract] [Full Text] [Related]
7. Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506.
Takara T; Tchervenkov JI; Guttman FM; Fecteau A; Rosenmann E
Transplant Proc; 1994 Jun; 26(3):1622. PubMed ID: 7518150
[No Abstract] [Full Text] [Related]
8. Intraportal injection of specific allogeneic cells can prolong neonatal intestinal free graft survival.
Lee SK; Perez-Atayde A; Takeda T; Vacanti JP; Lund DP
Transplant Proc; 1994 Jun; 26(3):1579-80. PubMed ID: 8030044
[No Abstract] [Full Text] [Related]
9. Tolerance for graft-versus-host disease by intrathymic injection of recipient-type splenocytes into donor.
Vaidya S; Wang CC; Roorda C; Billings A; Rajaraman S; Fish JC
Transplant Proc; 1997; 29(1-2):1073-5. PubMed ID: 9123205
[No Abstract] [Full Text] [Related]
10. Effects of preformed antibodies induced by whole blood transfusion on small bowel transplantation.
Fujisaki S; Murase N; Demetris AJ; Tanabe M; Todo S; Starzl TE
Transplant Proc; 1994 Jun; 26(3):1528-9. PubMed ID: 7518140
[No Abstract] [Full Text] [Related]
11. Beneficial immunosuppressive effect of FTY720 combined with intrathymic injection of splenic cells on rat pancreaticoduodenal allograft.
Suzuki K; Kazui T; Kawabe A; Li XK; Amemiya H; Suzuki S
Transplant Proc; 1998 Jun; 30(4):1067-8. PubMed ID: 9636432
[No Abstract] [Full Text] [Related]
12. Different response of intestinal and cardiac allografts to pretreatment with UV-B irradiated donor-specific leukocytes (DL) or DL alone.
Gundlach M; Oluwole SF; Pohland CC; Broelsch CE; Hardy MA
Transplant Proc; 1996 Oct; 28(5):2482-3. PubMed ID: 8907913
[No Abstract] [Full Text] [Related]
13. Induction of tolerance to an "untolerizable" strain by double-strain intrathymic inoculation in experimental rat cardiac transplantation.
Mohiuddin MM; Yokoyama H; Reiss GR; DiSesa VJ
Transplant Proc; 1999; 31(1-2):838-9. PubMed ID: 10083364
[No Abstract] [Full Text] [Related]
14. Graft survival and MLC response in LEW-ACI small bowel transplants treated with a novel MHC peptide, BC-1nl.
Tice DG; Bruch D; Squiers EC
Transplant Proc; 1998 Sep; 30(6):2590-1. PubMed ID: 9745504
[No Abstract] [Full Text] [Related]
15. Effect of simultaneous intrathymic injection of two unrelated cellular alloantigens on rat cardiac allograft survival.
Shimomura K; Hardy MA; Oluwole SF
Transplant Proc; 1995 Feb; 27(1):127. PubMed ID: 7878878
[No Abstract] [Full Text] [Related]
16. Prolonged small bowel graft survival using photochemotherapy and low-dose FK 506.
Toyama Y; Murase N; Galvao FH; Sakamoto T; Nomoto M; Starzl TE; Todo S
Transplant Proc; 1996 Oct; 28(5):2506-7. PubMed ID: 8907924
[No Abstract] [Full Text] [Related]
17. Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells.
Jin MX; Chowdhury NC; James T; Engelstad K; Hardy MA; Oluwole SF
Transplant Proc; 1993 Feb; 25(1 Pt 1):291. PubMed ID: 8438304
[No Abstract] [Full Text] [Related]
18. Small bowel transplantation in the rat: the effect of donor-specific transfusion 24 hours pretransplant and cyclosporine.
Fecteau A; Tchervenkov J; Guttman FM; Rosenmann E
Transplant Proc; 1992 Jun; 24(3):1166. PubMed ID: 1604571
[No Abstract] [Full Text] [Related]
19. Use of spleen transplantation and cyclosporine A treatment to ameliorate survival after small bowel transplantation.
Pirenne J; D'Silva M; Jacquet N
Transplant Proc; 1993 Feb; 25(1 Pt 2):1206. PubMed ID: 8442087
[No Abstract] [Full Text] [Related]
20. Graft immunomodulation by donor irradiation and recipient-specific bone marrow cells in rat small bowel transplantation.
Miyazawa H; Furuya T; Iida M; Kotanagi H; Koyama K
Transplant Proc; 2002 Jun; 34(4):1349-54. PubMed ID: 12072357
[No Abstract] [Full Text] [Related]
[Next] [New Search]
